checkAd

     389  0 Kommentare Cytokinetics Announces Upcoming Presentations at the 2023 HCMS Scientific Sessions and the HFSA Annual Scientific Meeting

    Baseline Characteristics from SEQUOIA-HCM to be Presented at HCMS Scientific Sessions on October 6, 2023

    SOUTH SAN FRANCISCO, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK), today announced upcoming presentations at the 2023 Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions on October 6, 2023, and at the Heart Failure Society of America (HFSA) Annual Scientific Meeting, taking place from October 6-9, 2023, both taking place in Cleveland, OH.

    2023 HCMS Scientific Sessions

    Poster Abstract Presentations

    Title: Baseline Characteristics of Patients in SEQUOIA-HCM: A Phase 3 Trial of Aficamten in Obstructive Hypertrophic Cardiomyopathy
    Presenter: Martin S. Maron, M.D., Director of the Hypertrophic Cardiomyopathy Center at Lahey Hospital and Medical Center
    Date: October 6, 2023
    Session Title: Poster Abstract Presentations
    Session Time: 1:00 – 1:45 PM ET
    Location: Hilton Cleveland Downtown

    HFSA Annual Scientific Meeting

    Poster Presentations

    Title: Characteristics and Procedural Complications of Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy in the United States
    Presenter: Ahmed Altibi, M.D., MPH, Cardiology Fellow, Division of Cardiovascular Medicine, Oregon Health & Science University
    Date: October 7, 2023
    Session Title: ePoster Viewing Sessions - ePoster Viewing Session II
    Poster Number: 139
    Session Time: 8:00 – 9:00 AM ET
    Presentation Time: 8:30 – 9:00 AM ET
    Location: Exhibit Hall‚ ePoster Hub

    Title: Symptoms and Complications Significantly Increase the Logistic and Economic Burden of Obstructive Hypertrophic Cardiomyopathy - Results from Medical and Pharmacy Claims Data
    Presenter: Meiling Chen, M.D., Cardiology Research Fellow, HCM Center of Excellence, University of California, San Francisco Medical Center
    Date: October 7, 2023
    Session Title: ePoster Viewing Sessions - ePoster Viewing Session III
    Poster Number: 163
    Session Time: 1:00 – 2:30 PM ET
    Presentation Time: 1:00 – 1:30 PM ET
    Location: Exhibit Hall‚ ePoster Hub

    Title: Cardiovascular Hospitalizations Post Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy: A 3-year Analysis of 5,101 Patients
    Presenter: Ahmed Altibi, M.D., MPH, Cardiology Fellow, Division of Cardiovascular Medicine, Oregon Health & Science University
    Date: October 7, 2023
    Session Title: ePoster Viewing Sessions - ePoster Viewing Session III
    Poster Number: 191
    Session Time: 1:00 – 2:30 PM ET
    Presentation Time: 1:30 – 2:00 PM ET

    Seite 1 von 3



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Cytokinetics Announces Upcoming Presentations at the 2023 HCMS Scientific Sessions and the HFSA Annual Scientific Meeting Baseline Characteristics from SEQUOIA-HCM to be Presented at HCMS Scientific Sessions on October 6, 2023SOUTH SAN FRANCISCO, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) - Cytokinetics, Incorporated (Nasdaq: CYTK), today announced upcoming presentations …

    Schreibe Deinen Kommentar

    Disclaimer